Hong Kong teen dies after being found unconscious in bedroom with ‘space oil' drug
A police source said on Monday that the teenager's mother had attempted to wake him at their home in Cheung Sha Wan at around 8.45am on Sunday.
He was rushed to Caritas Medical Centre in Sham Shui Po, where he was declared dead at 9.49am on Sunday.
A police spokesman said officers discovered multiple dangerous substances in the flat, including a vape device containing liquid etomidate, the main ingredient in the drug commonly known as 'space oil'. Cannabis and ketamine were also seized.
The source said the 'space oil' was inside the bedroom where the teenager was found. There were no suspicious injuries on his body, but he had multiple self-inflicted wounds on his shoulders and forearms.
The teenager did not leave the flat on Saturday. At around 5am the following morning, his father saw him using the bathroom and said he appeared normal.
The father also reminded him to take his prescribed psychiatric medication, which he did before returning to his room.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
South China Morning Post
14 minutes ago
- South China Morning Post
Love king crab but worried about allergies? Hong Kong researchers have solution
King crab is a favourite of Hong Kong seafood lovers, as long as they do not have a reaction to the delicacy, which was among six types of shellfish found to contain eight newly identified allergens. Advertisement A study led by Chinese University of Hong Kong academics looked at six types of crabs popular with local diners and found 11 allergens, including eight identified for the first time. Revealing their findings, the researchers said that a more precise diagnosis would allow patients to consume crabs to which they were not allergic. 'Crabs are one of the most important types of shellfish that cause allergic reactions,' said Leung Ting-fan, a paediatrics professor at the university. Crabs are the second largest cause of food allergy among Hong Kong pupils aged six to 11 after shrimp, affecting around 0.2 per cent of them, according to research published in 2020. Advertisement Crabs are a delicacy in Hong Kong, especially the most expensive king crabs, which can cost at least HK$1,800 for one weighing 2.5kg. The best season for king crabs is considered winter, with ones sourced from the cold waters of Alaska, Russia and Hokkaido in Japan highly prized.
South China Morning Post
19 minutes ago
- South China Morning Post
How can Hongkongers seek help for depression, and what treatment is available?
Hong Kong was shocked on Sunday by a suspected murder-suicide case in which a father with a history of mental health issues was believed to have taken his own life after killing his wife and two children at a Tsuen Wan hotel. No suicide note was found, but the 37-year-old man had posted on social media before the incident that he was struggling mentally and was very worried about not being able to take care of his family. A source said he had suffered from depression. Police psychologist Michael Fung Ho-kin explained that emotional illnesses could not be 'cured' by a hike or a meal after which the sufferer could 'go home and become happy again'. The Post looks at the prevalence of depression in the city and the different treatment strategies. 1. What is depression? Depression is a common mood disorder affecting 5 per cent of men and 10 per cent of women in developed countries. It is characterised by symptoms such as a persistently depressed mood, loss of interest and energy, and negative thoughts.
South China Morning Post
4 hours ago
- South China Morning Post
Cheaper drugs, revamped fees are healthy steps for Hong Kong
The accessible and affordable world-class public health system Hong Kong enjoys – and expects – comes at an ever-increasing price, amid an ageing society and the rising costs of medical and pharmaceutical advances. A revamp of the fee structure from next year, to recover more of the spiralling costs to the government's budget, was inevitable. Rightly, it is subject to measures to safeguard access for the most vulnerable members of society. It is good, therefore, to learn the government is going on the front foot in negotiations with pharmaceutical companies to get the best deals for many of the drugs that public patients need and the best value for the massive public investment in healthcare. As a result, patients can soon expect to pay about 20 per cent less for some drugs. Hospital Authority chief executive Dr Tony Ko Pat-sing anticipates savings to public funds of at least HK$1 billion (US$127 million) from measures including drug price reductions and expansion of sources of supplies. This is thanks in large part to a greater emphasis on a thorough procurement process. The Hospital Authority's chief pharmacist, William Chui Chun-ming, says when hospital drugs are reasonably priced, the authority can use the money saved to buy more new drugs or extend the range in stock. So far, he says, 70 per cent of drug makers, mostly from foreign countries, are willing to give discounts of an average of 20 per cent. The authority's negotiators used as a reference drug prices offered under the mainland's medical insurance system, which are generally lower due to the bargaining power of bulk procurement for a huge population. Beijing said last year that this had saved patients more than 880 billion yuan (US$123 billion). The potential for cost-effective optimisation of access to the latest pharmaceutical drugs will be enhanced by Hong Kong's aspiration to become an international medical and innovation hub, including a recognised clinical drug-trial centre. Chui said the authority would also monitor drugs in phase three clinical trials and approach developers for access to data with a view to adoption in public hospitals soon.
